EMA investigating 4 'serious cases' of blood clots following J&J vaccinations
The European Medicines Agency’s safety committee said last Friday that it has initiated a review of 4 “serious cases of unusual blood clots with low blood platelets,” including one death, reported after people received the J&J vaccine in the US.
The agency offered an update on Wednesday that it is expediting this evaluation and currently expects to issue a recommendation next week. “While its review is ongoing, EMA remains of the view that the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects,” the agency said in a statement. J&J announced on Tuesday that it would pause the distribution of its vaccine across Europe until the investigations are complete.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.